|
ELAVL1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.289700E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.489600E-01 |
| Normal-vs-Stage2 |
4.911400E-01 |
| Normal-vs-Stage3 |
5.643100E-03 |
| Normal-vs-Stage4 |
8.844200E-02 |
| Stage1-vs-Stage2 |
8.098800E-01 |
| Stage1-vs-Stage3 |
1.228410E-02 |
| Stage1-vs-Stage4 |
2.561800E-01 |
| Stage2-vs-Stage3 |
3.986400E-02 |
| Stage2-vs-Stage4 |
3.465400E-01 |
| Stage3-vs-Stage4 |
2.519600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.451600E-02 |
| Normal-vs-AfricanAmerican |
7.630400E-02 |
| Normal-vs-Asian |
3.905400E-01 |
| Caucasian-vs-AfricanAmerican |
4.487600E-01 |
| Caucasian-vs-Asian |
5.922600E-01 |
| AfricanAmerican-vs-Asian |
8.244000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.274800E-01 |
| Normal-vs-Female |
6.760600E-03 |
| Male-vs-Female |
6.954400E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.685200E-01 |
| Normal-vs-Extreme_Weight |
4.770800E-01 |
| Normal-vs-Obese |
7.441200E-03 |
| Normal-vs-Extreme_Obese |
4.096800E-01 |
| Normal_Weight-vs-Extreme_Weight |
6.822800E-01 |
| Normal_Weight-vs-Obese |
2.033800E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.843600E-01 |
| Extreme_Weight-vs-Obese |
3.749900E-02 |
| Extreme_Weight-vs-Extreme_Obese |
4.557000E-01 |
| Obese-vs-Extreme_Obese |
7.416600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.016200E-03 |
| Normal-vs-Age(41-60Yrs) |
1.615110E-03 |
| Normal-vs-Age(61-80Yrs) |
6.392800E-01 |
| Normal-vs-Age(81-100Yrs) |
3.300400E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.579380E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.818100E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.827800E-04 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.136700E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.772800E-04 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.339180E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.112300E-02 |
| Normal-VS-Type2 PRCC |
9.502000E-01 |
| Normal-VS-KIRP CIMP |
1.149950E-02 |
| Normal-VS-Unclassified PRCC |
7.087700E-02 |
| Type1 PRCC-VS-Type2 PRCC |
1.179970E-01 |
| Type1 PRCC-VS-KIRP CIMP |
3.903700E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
5.005800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.244000E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
1.163220E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.613800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.801200E-01 |
| Normal-vs-N1 |
4.441900E-03 |
| Normal-vs-N2 |
4.967600E-01 |
| N0-vs-N1 |
1.368340E-02 |
| N0-vs-N2 |
9.579600E-01 |
| N1-vs-N2 |
3.191600E-01 |
|
|
